We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CATX market cap is 182.49M. The company's latest EPS is USD -0.6881 and P/E is -3.95.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.19M | -4.9M | 325k | 526k | 369k |
| Operating Income | -10.55M | -10.4M | -13.01M | -14.27M | -18.63M |
| Net Income | -10.37M | -24.66M | -12.28M | -11.7M | -15.12M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 9.75M | 10.05M | 10.8M | 3.55M | 1.43M |
| Operating Income | -3.48M | -3.44M | -7.39M | -7.59M | -40.96M |
| Net Income | -3.46M | -3.39M | -7.27M | -7.34M | -46.51M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 110.52M | 97.89M | 278.29M | 385.92M | 391.15M |
| Total Liabilities | 11.75M | 22.71M | 48.4M | 44.92M | 62.68M |
| Total Equity | 98.77M | 75.18M | 229.89M | 341M | 328.47M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 8.7M | 70.42M | 64.44M | 58.09M | 97.89M |
| Total Liabilities | 2.98M | 3.01M | 3.16M | 3.45M | 22.71M |
| Total Equity | 5.72M | 67.41M | 61.28M | 54.64M | 75.18M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -27.91M | -36.91M | 13.85M | 4.95M | 8.31M |
| Investing | 24.46M | 24.37M | -47.3M | -50.59M | -80.33M |
| Financing | 433k | 785k | 166.33M | 288.41M | 289.04M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.64M | -2.84M | -7.71M | -6.09M | -36.91M |
| Investing | -287k | -410k | -284k | -28.84M | 24.37M |
| Financing | 994k | 64.68M | 56k | 28k | 785k |
| Market Cap | 182.49M |
| Price to Earnings Ratio | -3.95 |
| Price to Sales Ratio | 128.3 |
| Price to Cash Ratio | 19.9 |
| Price to Book Ratio | 2.45 |
| Dividend Yield | - |
| Shares Outstanding | 67.59M |
| Average Volume (1 week) | 653.3k |
| Average Volume (1 Month) | 535.37k |
| 52 Week Change | -73.27% |
| 52 Week High | 19.05 |
| 52 Week Low | 2.32 |
| Spread (Intraday) | 0.09 (3.23%) |
| Company Name | Perspective Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://perspectivetherapeutics.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
